EpiZyme Inc (EPZM) - Financial Analysis Review

Summary

EpiZyme Inc (Epizyme) is a clinical stage biopharmaceutical company that discovers and develops molecular targeted drugs for the treatment of cancer, metabolic diseases and other diseases. The companys product pipeline offers epigenetic therapies such as tazemetostat, the lead agent for the treatment of cancer. It also offers pinometostat in collaboration Celgene for treating pediatric MLL-r, a form of acute leukemia. Epizyme develops drugs for the treatment of refractory non-Hodgkin lymphoma, refractory synovial sarcoma and others. The company works in collaborations with pharmaceutical research companies and research foundations to develop small molecule oncology programs.

GlobalData's EpiZyme Inc (EPZM) - Financial Analysis Review provides a comprehensive insight into the company's history, business structure and operations. The report contains information on the company's key employees, key competitors and major products and services, as well as detailed financial ratios for the last 5 years.

EpiZyme Inc Key Recent Developments:

Nov 03,2016: Epizyme Provides Update on Execution of Clinical Program and Reports Third Quarter 2016 Financial Results
Sep 29,2016: Epizyme Appoints Pamela Strode as Vice President, Regulatory Affairs and Quality Assurance
Aug 08,2016: Epizyme Announces Second Quarter 2016 Financial Results
May 09,2016: Epizyme Announces First Quarter 2016 Financial Results and Provides Update on Execution Against Multi-Year Company Vision
May 06,2016: Epizyme Continues to Build Senior Leadership Team with Appointment of Matthew Ros as Chief Operating Officer


This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better.

Scope
- Business description - A detailed description of the company's operations and business divisions.
- Company history - Progression of key events associated with the company.
- Major products and services - A list of major products, services and brands of the company.
- Key competitors - A list of key competitors to the company.
- Key employees - A list of the key executives of the company.
- Executive biographies - A brief summary of the executives' employment history.
- Key operational heads - A list of personnel heading key departments/functions.
- Important locations and subsidiaries - A list of key locations and subsidiaries of the company, including contact details.
- Detailed financial ratios for the past five years - The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods - The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Note: Some sections may be missing if data is unavailable for the company.

Reasons to Buy

- Gain key insights into the company for academic or business research purposes. Key elements such as detailed business description and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
- Identify potential customers and suppliers with this report's analysis of the company's business structure, operations, major products and services.
- Examine potential investment and acquisition targets with this report's detailed insight into the company's business, financial and operational performance. Financial ratios presented for major public companies in the report include; revenue trends, profitab